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The hypothesis that inhibition of secretion by botulinum neurotoxin type D occurs by an intracellular process involving 
ADP-ribosylation has been directly tested by measuring both the extent of inhibition of secretion and of ADP-ribosyla- 
tion in the same cells. Although the inhibitory effect of unpurified toxin closely parallels intracellular ibosylation, the 
two events are clearly unrelated, as using purified D and C3 toxins together with their antibodies, each of these events 
can be either stimulated or inhibited independently of each other. 
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1. INTRODUCTION 
The mechanism by which botulinurn neurotox- 
ins inhibit exocytosis is unclear [ I] but in the case 
of the adrenal medullary cell they seem to act at or 
near the site of exocytosis itself, rather than in- 
hibiting the [Ca’+]i transient normally associated 
with secretion [2,3]. One popular hypothesis is that 
the neurotoxins are internalised by the cell, and 
secretion blocked when a small protein fragment is 
revealed [4-61. Other toxins, such as cholera and 
diphtheria, express their potencies through the 
ADP-ribosylase transferase activity of such a small 
fragment. As there are marked structural 
similarities between these toxins and botulinurn 
toxins, the idea has arisen that perhaps botulinum 
toxins might inhibit secretion by a similar method, 
i.e. one in which intracellular processing of the 
toxin reveals a small protein fragment which ADP- 
ribosylates a key protein associated with ex- 
ocytosis. Although two neurotoxins (types Cl and 
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D) have been reported to ADP-ribosylate a low 
molecular mass protein in the homogenate of 
adrenal medullary tissue [7-91, other evidence sug- 
gests that the ADP-ribosyltransferase activity is 
not associated with the whole neurotoxin but 
rather to a small protein ‘C3’ [lo-121 present with, 
but perhaps unrelated to, the larger whole 
neurotoxin [14-161. By exposing electroper- 
meabilised chromaffin cells to both toxins and 
labelled NAD we have been able to directly 
measure the extents of secretion and the associated 
levels of ADP-ribosylation. This paper therefore 
describes a series of experiments which address the 
following questions: (i) Is the ribosylation pattern 
triggered by toxin D the same as that triggered by 
toxin C3? (ii) Is the inhibitory effect on secretion 
of toxin D mimicked by toxin C3? (iii) Using 
purified toxins and their antibodies, can the 
botulinurn toxin type D-induced events of ribosyla- 
tion and inhibition of secretion be separated? Our 
results clearly show that botulinurn toxin-induced 
ADP-ribosylation and inhibition of secretion are 
distinct and unrelated events, and as such argue 
against a common underlying mechanism of action 
for both botulinum neurotoxin and cholera/ 
diphtheria toxins. 
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2. MATERIALS AND METHODS 
Three types of botulinum toxin were used, (a) unpurified tox- 
in type D (gift from E. Schantz, Wisconsin, USA), (b) purified 
toxin type C3 [10,12,14], and purified toxin type D (purified 
[17] and provided by Wako Co., Japan). Antibody to purified 
D neurotoxin was obtained from the National Institute for 
Biological Standards and Control, London, England, and the 
antibody to purified C3 toxin prepared as described previously 
[141. 
Bovine chromaffin cells were isolated and maintained in 
culture for 24 h as described previously [Z] before being 
suspended at 0°C in a potassium glutamate based medium 1181 
containing 1.50 mM potassium glutamate, 4 mM Mg acetate, 
2 mM MgATP, 20 mM Pipes, 18 mM thymidine, 0.1 mM 
GTP, 0.4 mM EGTA, pH 6.6, and 12pM [32P]NAD 
(lo&i/ml). The cells were incubated at 0°C for 15 min with 
various concentrations of toxin before being rendered leaky by 
exposure to brief intense electric fields [18] (10 exposures of 
2 kV/cm, 7 200 ps). After a further 10 min at 0°C followed by 
15 min at 37°C the Ca-dependent secretory response and the 
corresponding extent of ADP-ribosylation were determined. 
Secretion was measured by the amount of catecholamine 
secreted over a further 15 min period in response to raising the 
Ca*+ level from 0.01 pM to 1OpM using Ca-EGTA buffers 
[IS]. The extent of ribosylation was determined by precipitating 
the cell proteins in 12.5% trichloroacetic acid (TCA), centrifug- 
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ing at 0°C for 5 min at 12000 x g, washing the pellet in ethanol 
and ether, solubilising in Laemmli’s sample buffer and then 
electrophoresing on an SDS-polyacrylamide gel [19] or on a 2D 
gel [20]. The extent of ribosylation was quantified from den- 
sitometer traces of autoradiograms. 
3. RESULTS AND DISCUSSION 
Botulinum toxin type D inhibits both basal and 
evoked secretion from cultured bovine adrenal 
medullary cells [2,21]. The incubation time and 
doses needed to inhibit catecholamine secretion 
however are relatively high compared to that need- 
ed to block acetylcholine release at the 
neuromuscular junction. For example 5 pg of un- 
purified D toxin takes several days to block 
catecholamine secretion from cultured chromaffin 
cells whereas 0.5 ng is sufficient to inhibit 
acetylcholine release at the neuromuscular junc- 
tion within 24 h. The long incubation times are 
likely to reflect the inaccessibility of the toxin to 
the interior of the cell due to the effective barrier 
of the plasma membrane. The toxin is far more ef- 
fective, however (operating within minutes rather 
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Fig.1. (a) Unpurified botulinum toxin type D exposed to leaky chromaffin cells ADP-ribosylates a clearly visible protein close to 
24 kDa. (i) Molecular mass standards, (ii) Coomassie blue stained gel, (iii) ‘2P-labelled autoradiogram, (iv) densitometer trace of 
autoradiogram. (b,c) Autoradiograms showing that the intracellular protein, ADP-ribosylated by purified toxin C3, comigrates in 2D 
electrophoresis with that ADP-ribosylated by impure botulinum toxin type D. Electropermeabilised cells were incubated with either 
6 gg/ml of impure type D neurotoxin (a,c), or with 0.5 p&ml of purified toxin C3 (b). 
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than days), when exposed to chromaffin cells in 
which the plasma membrane has been rendered 
‘leaky’ by electric fields and the cells subsequently 
triggered to secrete by a micromolar Ca2+ 
challenge [18,22]. As this technique ‘peppers’ the 
secretory cell with holes of 4 nm effective diameter 
[18], [32P]NAD can also be introduced into the 
cytosol allowing the extent of ADP-ribosylation to 
be measured alongside Ca2+-dependent secretion. 
Such experiments how that when leaky cells are 
incubated with unpurified toxin D, both 
Ca2+-dependent secretion is inhibited and an in- 
tracellular protein with an approximate molecular 
mass of 24 kDa (P24) is ADP-ribosylated [23]. 
Fig. la shows this clear ribosylation pattern seen in 
toxin-treated electropermeabilised cells. The toxin 
dose response curves, incubation times, and 
temperature dependences for both the ribosylation 
of P24 and inhibition of secretion in the same 
leaky cells are very similar. For example, when 
leaky cells are exposed at 37°C to 5 pg of un- 
purified toxin D, half-maximal ribosylation and 
inhibition of secretion occurs within 4 min, 
whereas at 20°C 11 min of incubation are needed 
for both, and at 0°C the toxin is virtually without 
effect for over half an hour. 
In order to test if the ribosylation event is 
associated with the neurotoxin or with a contami- 
nant, such as C3 toxin, or what its relationship is 
to the inhibitory process, electropermeabilised 
chromaffin cells were exposed to purified toxins 
C3 and D. C3 toxin ADP-ribosylates a 24 kDa in- 
tracellular protein in leaky chromaffin cells that 
comigrates on 2D gel electrophoresis with the pro- 
tein ribosylated by impure toxin D (fig.lb,c). The 
sites of ribosylation on this protein are probably 
the same as the extent of ribosylation induced by 
saturating levels of C3 when no further enhance- 
ment is obtained by the addition of botulinum tox- 
in. Fig.2 shows the effect on secretion and 
ribosylation of introducing C3 toxin and purified 
toxins into the leaky cells. Although C3 fully ADP- 
ribosylates P24, secretion remains largely unaf- 
fected. Purified toxin D however, when presented 
to the leaky cells, fully inhibits secretion but shows 
little ribosylase activity. The activity associated 
with pure neurotoxin is less than 0.1 Vo of that in- 
duced by an equivalent weight of the unpurified 
toxin D. 
Incubation of C3 toxin with its antibody 
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Fig.2. Effect of botulinum toxins on the Ca-dependent 
secretory response and on the extent of ADP-ribosylation in 
leaky chromaffin cells. The left-hand ordinate shows the extent 
of inhibition of Ca-dependent secretion (a) and the right-hand 
ordinate of the extent of ribosylation in the cells (0). Cells 
exposed to (A) impure D toxin, (B) C3 toxin, and (C) purified 
toxin D. The amount secreted by cells not exposed to toxins was 
16% of the total cellular catecholamine content. 
neutralises its ADP-ribosyltransferase activity 
[14]. Fig.3 shows that this antibody also neutralises 
the ADP-ribosyltransferase activity of unpurified 
toxin D, but leaves unaltered the inhibitory effect 
on secretion of the toxin. Conversely the inhibitory 
effect of this unpurified toxin can be removed, but 
its ADP-ribosyltransferase activity left unaltered, 
by incubating with an antibody raised to purified 
toxin D. These data clearly separate the ribosyla- 
tion and inhibitory steps triggered by botulinum 
toxin. 
Further evidence dissociating these two steps 
comes from the finding that the presence of C3 
toxin, or the absence of NAD in the medium 
bathing the leaky cell do not alter the potency of 
the neurotoxin to block secretion. Furthermore 
treatment of toxin D with dithiothreitol, an agent 
which might be expected to release an active frag- 
ment [5,6], does not seem to alter the potency of 
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Fig.3. The ribosyltransferase component, but not the inhibitory 
component, of the impure neurotoxin D can be blocked by 
antibody to toxin C3, whereas the inhibitory effect, but not the 
ribosyltransferase activity can be removed by the antibody to 
the purified neurotoxin D. (A) The inhibitory effect and extent 
of ribosylation in cells exposed to the impure neurotoxin type 
D. (B) cells exposed to the impure toxin D preincubated for 
15 min at 0°C with antibody to toxin C3. The amount of 
antibody used was sufficient to neutralise the ribosyltransferase 
activity of 1 pg of C3. (C) Cells exposed to the impure toxin D 
preincubated as above with 5 IU of antibody to purified 
neurotoxin D (from the National Institute for Biological 
Standards and Control, London, England). The catecholamine 
secreted by cells not exposed to toxins was 14% of the cellular 
content. 
the toxin to block secretion. Finally if ADP- 
ribosylation were involved in the mechanism of 
botulinurn poisoning, then residual ADP- 
ribosyltransferase activity might be expected to be 
present in the lysates of cultured chromaffin cells 
in which exocytosis had been blocked by 
botulinum toxins. Cells poisoned by purified 
botulinum toxin type D (or A) however, do not 
possess such ribosyltransferase activity (see also 
[24]). Cells poisoned with unpurified D toxin do 
possess this activity, but as it can be neutralised by 
C3 antibodies, it is not attributed to the neurotoxic 
component of the toxin. 
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Taken together these data argue strongly against 
a role of ADP-ribosylation in the mechanism by 
which botulinurn toxins inhibit secretion. 
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